- Home
- LTRN vs PBK Comparison
LTRN vs PBK Comparison
Compare LTRN & PBK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
HOLD
Current Price
$3.98
Company Overview
Basic Information| Metric | LTRN | PBK |
|---|---|---|
| Founded | 2013 | N/A |
| Country | United States | Canada |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Power Generation |
| Sector | Health Care | Utilities |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 46.8M | 44.4M |
| IPO Year | 2020 | N/A |
Fundamental Metrics
Financial Performance| Metric | LTRN | PBK |
|---|---|---|
| Price | $3.98 | $0.67 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | 187.5K | ★ 2.3M |
| Earning Date | 05-14-2026 | N/A |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 18.65 | N/A |
| EPS | N/A | ★ N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $1.11 | $0.65 |
| 52 Week High | $5.74 | $0.86 |
Technical Indicators
Market Signals| Indicator | LTRN | PBK |
|---|---|---|
| Relative Strength Index (RSI) | 57.34 | 21.89 |
| Support Level | $3.89 | N/A |
| Resistance Level | $4.20 | $0.85 |
| Average True Range (ATR) | 0.32 | 0.09 |
| MACD | -0.03 | -0.01 |
| Stochastic Oscillator | 53.16 | 7.11 |
Price Performance
Historical Comparison LTRN
PBK
About LTRN Lantern Pharma Inc.
Lantern Pharma Inc is a biopharmaceutical company focused on developing oncology drug candidates using its artificial intelligence platform. The company utilizes its proprietary RADR platform to identify, develop, and advance small molecule therapies and antibody-drug conjugates, with a pipeline that includes three lead small molecule drug candidates (LP-300, LP-184, and LP-284) targeting solid tumors and blood cancers. It also advances programs through its subsidiary focused on central nervous system and brain cancers.